Literature DB >> 21602468

Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice.

Rita K Upmacis1, Hao Shen, Lea Esther S Benguigui, Brian D Lamon, Ruba S Deeb, Katherine A Hajjar, David P Hajjar.   

Abstract

Nitric oxide (NO) is an important vasoactive molecule produced by three NO synthase (NOS) enzymes: neuronal (nNOS), inducible (iNOS), and endothelial NOS (eNOS). While eNOS contributes to blood vessel dilation that protects against the development of hypertension, iNOS has been primarily implicated as a disease-promoting isoform during atherogenesis. Despite this, iNOS may play a physiological role via the modulation of cyclooxygenase and thromboregulatory eicosanoid production. Herein, we examined the role of iNOS in a murine model of thrombosis. Blood flow was measured in carotid arteries of male and female wild-type (WT) and iNOS-deficient mice following ferric chloride-induced thrombosis. Female WT mice were more resistant to thrombotic occlusion than male counterparts but became more susceptible upon iNOS deletion. In contrast, male mice (with and without iNOS deletion) were equally susceptible to thrombosis. Deletion of iNOS was not associated with a change in the balance of thromboxane A(2) (TxA(2)) or antithrombotic prostacyclin (PGI(2)). Compared with male counterparts, female WT mice exhibited increased urinary nitrite and nitrate levels and enhanced ex vivo induction of iNOS in hearts and aortas. Our findings suggest that iNOS-derived NO in female WT mice may attenuate the effects of vascular injury. Thus, although iNOS is detrimental during atherogenesis, physiological iNOS levels may contribute to providing protection against thrombotic occlusion, a phenomenon that may be enhanced in female mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602468      PMCID: PMC3154673          DOI: 10.1152/ajpheart.00667.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.

Authors:  Gary Pare; Andrée Krust; Richard H Karas; Sonia Dupont; Mark Aronovitz; Pierre Chambon; Michael E Mendelsohn
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

3.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

4.  Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS.

Authors:  S J Hewett; J K Muir; D Lobner; A Symons; D W Choi
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

5.  Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase.

Authors:  L J Marnett; T L Wright; B C Crews; S R Tannenbaum; J D Morrow
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

6.  Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis.

Authors:  L M Landino; B C Crews; M D Timmons; J D Morrow; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

Review 8.  Assessment of hemostatic risk factors in predicting arterial thrombotic events.

Authors:  David Feinbloom; Kenneth A Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-11       Impact factor: 8.311

Review 9.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

10.  Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice.

Authors:  Feng Wu; John X Wilson; Karel Tyml
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03-13       Impact factor: 3.619

View more
  6 in total

1.  Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.

Authors:  R H Bekendam; D Iyu; F Passam; J D Stopa; K De Ceunynck; O Muse; P K Bendapudi; C L Garnier; S Gopal; L Crescence; J Chiu; B Furie; L Panicot-Dubois; P J Hogg; C Dubois; R Flaumenhaft
Journal:  J Thromb Haemost       Date:  2018-10-12       Impact factor: 5.824

2.  Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.

Authors:  Stefany B A Cau; Fernando S Carneiro; Rita C Tostes
Journal:  Front Physiol       Date:  2012-06-25       Impact factor: 4.566

3.  Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.

Authors:  Sanjana Dayal; Ilya O Blokhin; Rochelle A Erger; Melissa Jensen; Erland Arning; Jeff W Stevens; Teodoro Bottiglieri; Frank M Faraci; Steven R Lentz
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

4.  Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats.

Authors:  Devi Ganesh; Prem Kumarathasan; Errol M Thomson; Carly St-Germain; Erica Blais; James Crapo; Renaud Vincent
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

5.  Effects of Inducible Nitric Oxide Synthase Inhibition on Cardiovascular Risk of Adult Endotoxemic Female Rats: Role of Estrogen.

Authors:  Jaqueline C Castardo-de-Paula; Blenda H de Campos; Lorena de Jager; Eric D T Amorim; Nágela G Zanluqui; Carine C de Farias; Luciana Higachi; Phileno Pinge-Filho; Décio S Barbosa; Marli C Martins-Pinge
Journal:  Front Physiol       Date:  2018-07-31       Impact factor: 4.566

6.  The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis.

Authors:  Manasa K Nayak; Madankumar Ghatge; Gagan D Flora; Nirav Dhanesha; Manish Jain; Kathleen R Markan; Matthew J Potthoff; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.